Formulary guidance and transparency from P&T to point of care


Reality Check on Chronic Heart Failure

Market access for chronic heart failure treatments reveals differences in payer coverage across each major channel, as well as specific trends in the drug landscape.  

To help make sense of this new research, MMIT's team of experts has analyzed the data for you and summarized the key findings:

  • Payer Insights: Unrestricted lives continue to increase across commercial and medicare lives.
  • Class Trends: How "influencer" organizations and new research shifts prescribing
  • Key Findings: A two-horse race to obtain the least restricted PA policies on key payer formularies

What can pharma do to curb this trend and overcome these challenges?

Get the data behind this change and how it could impact your market access plans from MMIT's team.  Their clinical and policy backgrounds provide a unique and expert perspective to help expand your knowledge in the class and guide your decision-making process.

Download the full Reality Check now.